Mark Massaro
Stock Analyst at BTIG
(3.15)
# 2,862
Out of 4,534 analysts
1015
Total ratings
36.6%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Reiterated: Buy | $28 → $45 | $38.37 | +17.28% | 33 | Jul 16, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $32 | $15.56 | +105.66% | 6 | Jul 2, 2026 | |
| GH Guardant Health | Reiterated: Buy | $160 → $190 | $148.07 | +28.32% | 48 | Jul 1, 2026 | |
| NTRA Natera | Reiterated: Buy | $260 → $270 | $262.63 | +2.81% | 78 | Jun 23, 2026 | |
| SOPH SOPHiA GENETICS | Reiterated: Buy | $8 | $6.33 | +26.38% | 18 | Jun 15, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 | $48.41 | +65.26% | 10 | Jun 1, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $4.84 | - | 23 | May 15, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $2.5 | $0.9693 | +157.92% | 24 | May 15, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $5.30 | - | 12 | May 14, 2026 | |
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.17 | - | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $0.4167 | +859.92% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $40 | $23.90 | +67.40% | 34 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $4.68 | +70.94% | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $13.34 | -17.54% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $130 | $125.14 | +3.88% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $21.86 | +0.64% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 → $90 | $60.65 | +48.39% | 35 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $4 | $3.15 | +26.98% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.24 | - | 34 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $9 → $5 | $7.55 | -33.77% | 27 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $76.20 | +109.97% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $563.81 | +41.89% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.13 | - | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $1.96 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0009 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $16.58 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $3.85 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $3.90 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $310 | $184.68 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $173 → $170 | $281.48 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $112 → $113 | $207.66 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.375 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $19.90 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $149 → $145 | $154.48 | n/a | 2 | May 7, 2015 |
CareDx
Jul 16, 2026
Reiterated: Buy
Price Target: $28 → $45
Current: $38.37
Upside: +17.28%
Caris Life Sciences
Jul 2, 2026
Reiterated: Buy
Price Target: $32
Current: $15.56
Upside: +105.66%
Guardant Health
Jul 1, 2026
Reiterated: Buy
Price Target: $160 → $190
Current: $148.07
Upside: +28.32%
Natera
Jun 23, 2026
Reiterated: Buy
Price Target: $260 → $270
Current: $262.63
Upside: +2.81%
SOPHiA GENETICS
Jun 15, 2026
Reiterated: Buy
Price Target: $8
Current: $6.33
Upside: +26.38%
Tempus AI
Jun 1, 2026
Reiterated: Buy
Price Target: $80
Current: $48.41
Upside: +65.26%
Insight Molecular Diagnostics
May 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.84
Upside: -
Lucid Diagnostics
May 15, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9693
Upside: +157.92%
Alpha Teknova
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.30
Upside: -
MaxCyte
May 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.17
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $7 → $4
Current: $0.4167
Upside: +859.92%
May 13, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $23.90
Upside: +67.40%
May 12, 2026
Reiterated: Buy
Price Target: $9 → $8
Current: $4.68
Upside: +70.94%
May 11, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $13.34
Upside: -17.54%
May 7, 2026
Maintained: Buy
Price Target: $140 → $130
Current: $125.14
Upside: +3.88%
May 6, 2026
Reiterated: Buy
Price Target: $22
Current: $21.86
Upside: +0.64%
May 5, 2026
Reiterated: Buy
Price Target: $170 → $90
Current: $60.65
Upside: +48.39%
May 1, 2026
Upgraded: Buy
Price Target: $4
Current: $3.15
Upside: +26.98%
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.24
Upside: -
Mar 12, 2026
Rated: Sell
Price Target: $9 → $5
Current: $7.55
Upside: -33.77%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $76.20
Upside: +109.97%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $563.81
Upside: +41.89%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.13
Upside: -
May 20, 2024
Maintained: Buy
Price Target: $2
Current: $1.96
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0009
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Nov 17, 2019
Maintained: Buy
Price Target: $70 → $75
Current: $16.58
Upside: n/a
Nov 10, 2019
Maintained: Hold
Price Target: $7 → $8
Current: $3.85
Upside: n/a
Nov 6, 2019
Maintained: Buy
Price Target: $35
Current: $3.90
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $300 → $310
Current: $184.68
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $173 → $170
Current: $281.48
Upside: n/a
Oct 22, 2019
Maintained: Buy
Price Target: $112 → $113
Current: $207.66
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.375
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $19.90
Upside: n/a
May 7, 2015
Maintained: Hold
Price Target: $149 → $145
Current: $154.48
Upside: n/a